ES2060127T3 - Halogenoalquilfenil-alcoholes-cetonas y sus hidratos. - Google Patents

Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.

Info

Publication number
ES2060127T3
ES2060127T3 ES90810608T ES90810608T ES2060127T3 ES 2060127 T3 ES2060127 T3 ES 2060127T3 ES 90810608 T ES90810608 T ES 90810608T ES 90810608 T ES90810608 T ES 90810608T ES 2060127 T3 ES2060127 T3 ES 2060127T3
Authority
ES
Spain
Prior art keywords
hydrates
halogenoalkylphenyl
ketones
alcohols
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90810608T
Other languages
English (en)
Inventor
Sylvain Cottens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of ES2060127T3 publication Critical patent/ES2060127T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

EL INVENTO, SE REFIERE A HALOGENOALQUILOFENILOALCOHOLES HALOGENOALQUILOFENILOCETONAS Y SUS HIDRATOS DE FORMULA (I). TRATA DE UN PROCEDIMIENTO PARA LA PRODUCCION DE COMPUESTOS DE FORMULA (I) Y DESCRIBE SU APLICACION COMO TERAPEUTICO. TENIENDO R1 A R8 UN SIGNIFICADO DESCRITO EN LA PATENTE.
ES90810608T 1989-08-16 1990-08-14 Halogenoalquilfenil-alcoholes-cetonas y sus hidratos. Expired - Lifetime ES2060127T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927049A DE3927049A1 (de) 1989-08-16 1989-08-16 Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2060127T3 true ES2060127T3 (es) 1994-11-16

Family

ID=6387229

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90810608T Expired - Lifetime ES2060127T3 (es) 1989-08-16 1990-08-14 Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.

Country Status (18)

Country Link
US (1) US5166181A (es)
EP (1) EP0413667B1 (es)
JP (1) JPH03101643A (es)
KR (1) KR910004539A (es)
AT (1) ATE95166T1 (es)
AU (1) AU632844B2 (es)
CA (1) CA2023233A1 (es)
CZ (1) CZ411391A3 (es)
DE (2) DE3927049A1 (es)
DK (1) DK0413667T3 (es)
ES (1) ES2060127T3 (es)
FI (1) FI904025A7 (es)
HU (1) HUT58686A (es)
IE (1) IE902938A1 (es)
IL (1) IL95370A0 (es)
NZ (1) NZ234902A (es)
PT (1) PT94997A (es)
ZA (1) ZA906506B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
JP2000506892A (ja) * 1996-03-19 2000-06-06 ジー．ディー．サール アンド カンパニー ヘルペスウイルス感染症を治療するための求電子性ケトン
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
IT1304904B1 (it) * 1998-09-11 2001-04-05 Eisai Co Ltd Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
JP4639042B2 (ja) * 2003-09-29 2011-02-23 富士フイルムファインケミカルズ株式会社 ハロゲン−リチウム交換反応を用いる有機化合物の製造法
WO2008006286A1 (fr) 2006-07-05 2008-01-17 Tianjin Hemay Bio-Tech Co. Ltd Dérivés analgésiques 5,9 - méthanocyclo-octa (b) pyridine - 2 (1h) - one, leur procédé de préparation et leur utilisation
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
MX384391B (es) 2015-05-22 2025-03-14 Agenebio Inc Composiciones farmacéuticas de levetiracetam de liberación extendida.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840617A (en) * 1954-10-25 1958-06-24 Shell Dev New polyols, their preparation and derivatives
DE1934130A1 (de) * 1968-07-26 1970-01-29 Boehringer Sohn Ingelheim Acylphenylalkylamine und ihre Herstellung
US3996279A (en) * 1973-01-02 1976-12-07 Gerot-Pharmazeutika Dr. Walter Otto K.G. Novel 2-amino methyl-4,6-dihalogenphenol derivatives and methods for the preparation thereof
US4211794A (en) * 1979-01-08 1980-07-08 Pfizer Inc. N,N-Disubstituted aminomethylphenylethanolamines
JPS62252737A (ja) * 1986-04-01 1987-11-04 Japan Tobacco Inc アルデヒドまたはケトンのアルコールへの還元方法
EP0432719A1 (en) * 1989-12-14 1991-06-19 Hoechst-Roussel Pharmaceuticals Incorporated Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
PT94997A (pt) 1991-04-18
JPH03101643A (ja) 1991-04-26
AU6101590A (en) 1991-02-21
KR910004539A (ko) 1991-03-28
CZ411391A3 (en) 1994-01-19
ZA906506B (en) 1992-04-29
EP0413667A1 (de) 1991-02-20
HU904868D0 (en) 1991-01-28
IL95370A0 (en) 1991-06-30
CA2023233A1 (en) 1991-02-17
ATE95166T1 (de) 1993-10-15
DE3927049A1 (de) 1991-02-21
DE59002905D1 (de) 1993-11-04
US5166181A (en) 1992-11-24
NZ234902A (en) 1993-01-27
IE902938A1 (en) 1991-02-27
FI904025A7 (fi) 1991-02-17
FI904025A0 (fi) 1990-08-14
DK0413667T3 (da) 1993-11-08
HUT58686A (en) 1992-03-30
EP0413667B1 (de) 1993-09-29
AU632844B2 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
MX9205573A (es) Nuevas 9-amino-7-(amino substituido)-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composicion farmaceutica que las contiene
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
ES2190440T3 (es) Compuestos antitumorales, composiciones farmaceuticas, modos de preparacion y para el tratamiento.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2000036T3 (es) Producto cosmetico a base de n-hidroxipropilquitosanas, nuevas n-hidroxipropilquitosanas, asi como procedimiento para su fabricacion.
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
ES2087107T3 (es) Sulfonilaminocarboniltriazolinonas.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
DE69007337D1 (de) Gaserzeugende Zusammensetzungen, die Salze der 5-Nitro-Barbitursäure oder Salze der Nitro-Orotsäure oder 5-Nitro-Uracil enthalten.
ES2115904T3 (es) Derivados amino ramificados del tiazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR013462A1 (es) Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos
ES2042488T3 (es) Productos intermedios para la produccion de podofilotoxina, y compuestos relacionados y procedimientos para su preparacion y utilizacion.
IL61285A0 (en) 2-hydroxyalkyl-3,4,k-trihydroxy-piperidine compounds, their production and pharmaceutical compositions containing them
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
DK0565631T3 (da) Antivirale forbindelser
ES2051954T3 (es) 2-aminotiazoles substituidos.
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 413667

Country of ref document: ES